https://www.southampton.ac.uk/research/projects/ottensmeier-phase-1-trial-of-the-compound-ima950-in-glioblastoma-patients
Ottensmeier Phase 1 trial of the compound IMA950 in glioblastoma patients | University of...
Ottensmeier Phase 1 trial of the compound IMA950 in glioblastoma patients.
of the
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01369
Glioblastoma Multiforme Multipeptide Vaccine IMA950 and Poly ICLC with or without Varlilumab in...
Glioblastoma Multiforme Multipeptide Vaccine IMA950 and Poly ICLC with or without Varlilumab in Treating Patients with Newly Diagnosed or Recurrent Grade II...